Results 171 to 180 of about 1,828 (217)

Intraoperative Use of Nondepolarizing Neuromuscular Blocking Agents During Cardiac Surgery and Postoperative Pulmonary Complications: A Prospective Randomized Trial

Journal of Cardiothoracic and Vascular Anesthesia, 2018
Nondepolarizing neuromuscular blocking agents (NMBAs) are associated with perioperative complications in noncardiac surgery; however, little is known about their effect on cardiac surgery. This study assessed the effect of neuromuscular blockade (NMB) on the incidence of postoperative pulmonary complications (PPCs) after cardiac surgery and operating ...
Rebecca M. Gerlach, Sajid Shahul, Kristen Wroblewski, Elizabeth K. Cotter, Blake W. Perkins, John-Henry Harrison, Takeyoshi Ota, Valluvan Jeevanandam, Mark A. Chaney   +8 more
openalex   +3 more sources

Reversal of nondepolarizing neuromuscular blocking agents

Seminars in Anesthesia, Perioperative Medicine and Pain, 1995
Aaron F. Kopman
openalex   +2 more sources

Pharmacology of G‐1–64, a new nondepolarizing neuromuscular blocking agent with rapid onset and short duration of action

Acta Anaesthesiologica Scandinavica, 1999
Background: Chances are slim that a clinically useful ultra‐short‐acting neuromuscular blocking agent of rapid onset will emerge from the benzylisoquinolinium or the aminosteroid series to which all currently popular relaxants belong. G‐1–64 is a promising prototype of a new series of bis‐quaternary ammonium salt of bistropinyl diester derivatives we ...
Laszlo Gyermek, C Lee, Nhung T. T. Nguyen   +2 more
openalex   +3 more sources

CLINICAL NEUROMUSCULAR PHARMACOLOGY OF BW785U, AN ULTRA-SHORT–ACTING NONDEPOLARIZING ESTER NEUROMUSCULAR BLOCKING AGENT

Anesthesiology, 1980
John J. Savarese, H. H. Ali, S. J. Basta, Frederic M. Ramsey, Carl E. Rosow, P. W. Lebowitz, Charles G. Lineberry, Gilles Cloutier   +7 more
openalex   +2 more sources

The pharmacology of GW280430A: A new nondepolarizing neuromuscular blocking agent

Seminars in Anesthesia, Perioperative Medicine and Pain, 2002
Cynthia A. Lien
openalex   +2 more sources

Vecuronium: A New Nondepolarizing Neuromuscular‐Blocking Agent; Clinical Pharmacology, Pharmacokinetics, Cardiovascular Effects and Use in Special Clinical Situations

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1984
Vecuronium provides additional flexibility to the clinician using neuromuscular‐blocking drugs. Its shorter duration of action, lack of significant cardiovascular effects and lack of dependence on the kidney for elimination provide clinical advantages over, or alternatives to, currently available, nondepolarizing neuromuscular‐blocking drugs.
Ronald D. Miller
openalex   +3 more sources

A862 G1–64, A NEW, RAPIDLY ACTING NONDEPOLARIZING NEUROMUSCULAR BLOCKING AGENT

Anesthesiology, 1990
Laszlo Gyermek, Nam C. Nguyen, C. Lee
openalex   +2 more sources

Factors Affecting Administration of Nondepolarizing Neuromuscular Blocking Agents

ASA Refresher Courses in Anesthesiology, 1980
Jay Ham
openalex   +2 more sources

Effects of nondepolarizing neuromuscular blocking agents on erythrocytes in vitro

American Journal of Health-System Pharmacy, 1984
Demitri A. Cozanitis
  +5 more sources

Cisatracurium: a new nondepolarizing neuromuscular blocking agent.

Connecticut medicine, 1996
Casey A. Owens, James J. Brakoniecki
openalex   +2 more sources